nach oben

Erschienen in:

01.11.2020 | News item

French authority indicted over sodium valproate-related birth defects

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

The National Agency for Medicine and Health Product Safety (ANSM) in France has been indicted for "injuries and involuntary homicides through negligence" due to its failure to stop women receiving sodium valproate [Depakine; Sanofi; and generic formulations] during pregnancy, resulting in congenital abnormalities and other disorders in their children, reports Owen Dyer from Montreal, Canada, in the BMJ. …

Dyer O. France's drug regulator is indicted for manslaughter over sodium valproate birth defects. BMJ : 13 Nov 2020. Available from: URL: https://www.bmj.com/content/371/bmj.m4446

Titel: French authority indicted over sodium valproate-related birth defects
Publikationsdatum: 01.11.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-86261-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

French authority indicted over sodium valproate-related birth defects

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Brentuximab vedotin/rituximab

Antineoplastics

Benralizumab

Alemtuzumab

Warfarin

Bortezomib